Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
3D Systems | DDD | Apr 30, 2024 | 3.35 | -2.90 |
3M | MMM | Apr 30, 2024 | 96.51 | +4.72 |
4D Molecular Therapeutics | FDMT | Apr 30, 2024 | 23.93 | -1.32 |
51Talk Online Education Group ADR | COE | Apr 30, 2024 | 7.12 | +6.43 |
5E Advanced Materials | FEAM | Apr 30, 2024 | 1.15 | +4.55 |
60 Degrees Pharmaceuticals | SXTP | Apr 30, 2024 | 0.23 | -3.45 |
7-10 Yr Trsy Bear 3X Direxion | TYO | Apr 30, 2024 | 15.48 | +1.44 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Apr 30, 2024 | 23.39 | -1.56 |
7-10 Yr Trsy Ishares | IEF | Apr 30, 2024 | 91.43 | -0.47 |
89bio | ETNB | Apr 30, 2024 | 8.51 | -0.23 |
8x8 | EGHT | Apr 30, 2024 | 2.21 | -7.14 |
908 Devices | MASS | Apr 30, 2024 | 5.70 | -0.96 |
99 Acquisition Group | NNAG | Apr 30, 2024 | 10.38 | -0.67 |
99 Acquisition Group | NNAGU | Apr 30, 2024 | 10.61 | 0.00 |
9F ADR | JFU | Apr 30, 2024 | 3.18 | -8.62 |
A SPAC I Acquisition Unit | ASCAU | Apr 30, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | Apr 30, 2024 | 11.09 | -0.44 |
A-Mark Precious Metals | AMRK | Apr 30, 2024 | 40.07 | -2.39 |
a.k.a Brands | AKA | Apr 30, 2024 | 14.51 | +9.51 |
A.O Smith | AOS | Apr 30, 2024 | 82.84 | -1.74 |
A10 Networks | ATEN | Apr 30, 2024 | 13.06 | -2.54 |
A2Z Smart Technologies | AZ | Apr 30, 2024 | 0.41 | -3.40 |
AAA - A Rated Corporate Bond Ishares | QLTA | Apr 30, 2024 | 46.08 | -0.45 |
Aadi Bioscience | AADI | Apr 30, 2024 | 1.92 | +3.23 |
AAON | AAON | Apr 30, 2024 | 94.09 | +0.26 |
AAR | AIR | Apr 30, 2024 | 69.14 | -0.10 |
Abacus Life | ABL | Apr 30, 2024 | 11.96 | +1.01 |
Abbott Laboratories | ABT | Apr 30, 2024 | 105.97 | -1.21 |
AbbVie | ABBV | Apr 30, 2024 | 162.64 | +0.69 |
AbCellera Biologics | ABCL | Apr 30, 2024 | 3.78 | -1.56 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.